Research Developments in Atopic Dermatitis
By Annenberg Center for Health Sciences at Eisenhower
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 10
Description
Welcome to this activity focusing on new research related to atopic dermatitis presented as posters at the 2020 virtual annual meetings of the American Academy of Dermatology and the American Academy of Allergy, Asthma, and Immunology. The posters focus on new data related to the use of advanced therapies for atopic dermatitis. Beyond discussing the methods and results of each poster, the faculty, Drs. Steven Feldman and Alan Fleischer, Jr., share their views on the implication of the trial results on clinical practice.
| Episode | Date |
|---|---|
|
Introduction and Overview
|
Sep 08, 2020 |
|
Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis
|
Sep 08, 2020 |
|
Safety, Efficacy and Pharmacokinetics of Crisaborole Ointment 2% in Infants Age Three to Less Than 24 Months with Mild-to-Moderate Atopic Dermatitis
|
Sep 08, 2020 |
|
Association Between an Itch-Free State in Atopic Dermatitis Treated with Ruxolitinib Cream and Systemic Inflammatory Mediators
|
Sep 08, 2020 |
|
Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension
|
Sep 08, 2020 |
|
Patient-reported Outcome, or PROs, with Abrocitinib Treatment in Patients with Moderate to Severe Atopic Dermatitis
|
Sep 08, 2020 |
|
Peak Pruritus Numeric Rating Scale, the PPNRS, Response with Abrocitinib in Patients with Moderate to Severe Atopic Dermatitis: Results from a Randomized Phase 3 Clinical Trial
|
Sep 08, 2020 |
|
Dupilumab Treatment Results in Rapid Improvement in Itch in Adults and Adolescent Patients with Moderate to Severe Atopic Dermatitis
|
Sep 08, 2020 |
|
Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: An Analysis of a Retrospective Claims Database
|
Sep 08, 2020 |
|
Other posters of interest
|
Sep 08, 2020 |